Durham, NC, United States of America

O Elmo Millner, Deceased


Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 65(Granted Patents)


Company Filing History:


Years Active: 1994-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: O Elmo Millner: A Legacy of Innovation in Beta-Lactamase Research

Introduction

O Elmo Millner was a notable inventor whose contributions to the field of biochemistry have left a lasting impact. He was based in Durham, NC, and held a total of four patents during his career. His work primarily focused on the development of substrates for beta-lactamase, which are crucial in antibiotic resistance research.

Latest Patents

Millner's latest patents include innovative methods for synthesizing chromogenic and fluorogenic beta-lactamase substrates. These substrates are designed to be substantially colorless or nonfluorescent beta-lactam compounds that incorporate an electronegative leaving group. The leaving group can consist of a carbamate, carbonate, thiocarbamate, or thiocarbonate linkage, along with a fluorescent moiety or a moiety capable of producing a visually detectable colored product. Upon the cleavage of the lactam ring by beta-lactamase, the leaving group is liberated, resulting in the production of fluorescence or a colored product.

Career Highlights

Throughout his career, Millner worked at Becton Dickinson and Company Limited, where he made significant advancements in the detection of beta-lactamase. His innovative approaches have contributed to the understanding and management of antibiotic resistance, a critical issue in modern medicine.

Collaborations

Millner collaborated with several esteemed colleagues, including J Michael Quante and Randal A Hoke. These partnerships fostered a collaborative environment that enhanced the research and development of beta-lactamase substrates.

Conclusion

O Elmo Millner's contributions to the field of biochemistry, particularly in the area of beta-lactamase research, have been invaluable. His innovative patents and collaborative efforts have paved the way for advancements in antibiotic resistance detection and management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…